Stephen Hemsley, leader of giant UnitedHealth Group, for years has made private investments in healthcare startups, including firms that do business with—or compete against—UnitedHealth. The investments, involving tens of millions of dollars and stretching back at least seven years, weren't announced by the healthcare companies that he was investing in, and UnitedHealth never told its shareholders about them. Hemsley, 73, has been a dominant force at UnitedHealth for the past two decades. He began his second stint as chief executive last May, returning to help stabilize the finances of the behemoth he helped build. He previously served for more than a decade as CEO, then as chairman since 2017. In 2019, while he was UnitedHealth board chairman, Hemsley founded an investment firm, Cloverfields Capital Group LP, which is registered with the Securities and Exchange Commission as an investment adviser. Cloverfields, which he still owns, has said in filings that it invests in publicly held companies such as elevator-maker Otis Worldwide. But Cloverfields has a less-visible side, The Wall Street Journal found. Cloverfields Capital and entities affiliated with it have bought stakes in privately held healthcare startups. The investment targets spanned a range of healthcare interests, from a vaccine administration firm that did business with UnitedHealth to a provider of digital health services that offers a product that competes with it.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
